An MRI result with color gradations shows smaller metastases that current clinical scans might miss.
A new method to detect cancer in its early stages using a targeted MRI contrast agent that binds to proteins has been identified by a team of researchers led by Georgia State University Regents’ Professor Jenny Yang.
In their study, published in the journal Science Advances, Yang and her colleagues at Georgia State and Emory University describe a newly identified biomarker for detection of liver metastases. With current tests like biopsies, cancer in the liver is often detected in advanced stages, which can limit treatment options and lower overall survival rates. The discovery could have wide-ranging impacts, including more effective diagnosis and precision treatment, and less risk to patients.
“This is a game changer. It has the possibility to have many more applications, really for any type of cancer,” said Yang. “We are already applying it to 10 different types of cancer in the lab.”
The researchers, whose work is funded by the National Cancer Institute, developed an agent that can target certain receptors — in this case, chemokine receptor 4 (CXCR4). The receptor is overexpressed in common metastasis organs, such as the liver, among people who have cancer.
The CXCR4 targeted protein-based MRI contrast agent is expected to overcome major barriers in early diagnosis by showing even tiny instances of cancer cells on multi-color scans called precision MRI (pMRI), a new imaging methodology.
Using MRI technology, contrast agents carry the element gadolinium to enhance the images. During her previous work analyzing calcium, Yang decided to test how a metal, like gadolinium, would interact with protein. The protein wraps around the element and carries it to the site for imaging. Yang’s team found that protein design is much more effective in targeting the signs of disease.
“Currently, it is difficult to see early stages of disease in the liver, even in invasive biopsy,” said Yang. “Diagnostic testing using this contrast agent can not only identify the presence of disease but differentiate the stages of disease with high sensitivity and accuracy. That’s the beauty of this work.”
The findings are so promising, the targeted protein contrast agent is now being fast-tracked by the U.S. Food and Drug Administration (FDA) in the first step toward clinical trials to gauge its efficacy in humans.
“We have already met with the FDA, so we have a blueprint,” said Yang. “We hope within 18 months to two years we can conduct our first clinical trials in patents.”
Yang, who is also the associate director of the Center for Diagnostics and Therapeutics, holds 17 U.S. and 18 foreign patents in protein engineering. She recently became the university’s first professor to be awarded a fellowship by the National Academy of Inventors. Her start-up company InLighta Biosciences has been a key channel to allow her to compete for important funding and bring new discoveries to the marketplace.
The research builds on a 2019 study published in the journal Nature Communications, in which Yang’s team identified the first early detection of liver fibrosis using a collagen-targeted protein contrast agent. Combined, these studies represent the work of more than a dozen scientists from universities across the U.S., and their discoveries could help transform a $300 million industry that has seen few advances in the past several decades.
“We have been using the same contrast agents for 30 years with few breakthroughs,” said Yang. “I think this is my biggest scientific contribution. And I hope there are many more to come.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Detecting early-stage cancer
- Silent signals: Know unseen signs and symptoms of cancer for swift detection
Watch out for these red flags or key symptoms of cancer that are often missed and other expert insights for early detection ...
- New method could detect early ovarian cancer from urine samples,claims research
New research by Joseph Reiner and colleagues at Virginia Commonwealth University shows promise for a urine-based test for ovarian cancer. Reiner will present their research at the 68th ...
- Detecting cancer in minutes possible with just a drop of dried blood and new test, study hints
Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer.
- AI platform doubles detection rates for early-stage esophageal cancer
HANGZHOU -- A group of Chinese scientists have developed an artificial intelligence (AI) platform that doubles the detection rate for early-stage esophageal cancer.
- The importance of detecting colorectal cancer
Right now, the recommended age for a person of average risk to start having colonoscopy screenings has been lowered from 50 to 45.
Go deeper with Google Headlines on:
Detecting early-stage cancer
[google_news title=”” keyword=”detecting early-stage cancer” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Detecting cancer
- New AI-powered test could quickly detect three major cancer types - using a single drop of dried blood
A brand new method of testing powered by AI could one day be used to diagnose the early stages of three of the deadliest cancers - using just a single drop of dried blood. Chinese researchers have ...
- ‘Too Hot to Handle’ Alum Harry Jowsey Says His Doctors ‘Found Skin Cancer on Me’
Too Hot to Handle’ alum Harry Jowsey says his doctors have ‘found skin cancer’ but assures fans that he is going to be fine ...
- Dozens attend prostate cancer early detection event in Isle of Wight Co.
Men packed a community room in a Rushmere-area church on Saturday to learn about prostate cancer before getting screened.
- Breast cancer rates rising among Canadian women in their 20s, 30s and 40s
Rates of breast cancer in women under the age of 50 are rising in Canada according to a study which showed an increase in breast cancer diagnoses among females in their twenties, thirties, and forties ...
- Researchers create an AI-powered digital imaging system to speed up cancer biopsy results
University of Waterloo researchers have invented a digital medical imaging system that significantly improves the cancer detection process to deliver immediate results and enable swift, effective ...
Go deeper with Google Headlines on:
Detecting cancer
[google_news title=”” keyword=”detecting cancer” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]